FGFR1 and neoplasm: To determine if the FGFR inhibitor could overcome FGFR1-mediated effects in vivo, we implanted MCF-7eGFP and MCF-7FGFR1 cells in ovariectomized athymic mice supplemented with a 14-day release 17β-estradiol pellet to support initial tumor establishment.